Literature DB >> 8797725

Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection.

W W Hall1, R Ishak, S W Zhu, P Novoa, N Eiraku, H Takahashi, M da C Ferreira, V Azevedo, M O Ishak, O da C Ferreira, C Monken, T Kurata.   

Abstract

Human T lymphotropic virus, type II (HTLV-II), infection has been shown to be endemic in a number of American Indian populations, and high rates of infection have also been documented in intravenous drug abusers in urban areas throughout the world. Although the role of HTLV-II in human disease has yet to be clearly defined, there is accumulating evidence that like HTLV-I, infection may also be associated with rare lymphoproliferative and neurological disorders. In this article we review and summarize the epidemiology, molecular properties and clinical features of HTLV-II infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797725     DOI: 10.1097/00042560-199600001-00031

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  28 in total

1.  Molecular characterization and phylogenetic analyses of a new, highly divergent simian T-cell lymphotropic virus type 1 (STLV-1marc1) in Macaca arctoides.

Authors:  R Mahieux; J Pecon-Slattery; A Gessain
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study.

Authors:  A E Ades; S Parker; J Walker; M Edginton; G P Taylor; J N Weber
Journal:  BMJ       Date:  2000-06-03

3.  HTLV-I-associated myelopathy: are ferritin, S100beta protein, or guanine nucleotides CSF markers of disease?

Authors:  Andrea Regner; Ottomar Bianchini; Claudio Jardim; Marcio Menna-Barreto
Journal:  J Neurovirol       Date:  2002-02       Impact factor: 2.643

4.  Evaluation of the INNO-LIA HTLV I/II assay for confirmation of human T-cell leukemia virus-reactive sera in blood bank donations.

Authors:  E C Sabino; M Zrein; C P Taborda; M M Otani; G Ribeiro-Dos-Santos; A Sáez-Alquézar
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes.

Authors:  M Salemi; M Lewis; J F Egan; W W Hall; J Desmyter; A M Vandamme
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

6.  Molecular epidemiology of simian T-cell lymphotropic virus type 1 in wild and captive sooty mangabeys.

Authors:  Vicki L Traina-Dorge; Rebecca Lorino; Bobby J Gormus; Michael Metzger; Paul Telfer; David Richardson; David L Robertson; Preston A Marx; Cristian Apetrei
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

7.  One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3.

Authors:  Guillaume Besson; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2009-02-11       Impact factor: 5.948

8.  Preexisting infection with human T-cell lymphotropic virus type 2 neither exacerbates nor attenuates simian immunodeficiency virus SIVmac251 infection in macaques.

Authors:  Shari N Gordon; Anna R Weissman; Valentina Cecchinato; Claudio Fenizia; Zhong-Min Ma; Tzong-Hae Lee; Lorenzo Zaffiri; Vibeke Andresen; Robyn Washington Parks; Kathryn S Jones; Jean Michel Heraud; Maria Grazia Ferrari; Hye Kyung Chung; David Venzon; Renaud Mahieux; Edward L Murphy; Steven Jacobson; Christopher J Miller; Francis W Ruscetti; Genoveffa Franchini
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

9.  Human T-cell lymphotropic virus type 1 tax among American blood donors.

Authors:  D Zucker-Franklin; B A Pancake
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

10.  Molecular evidence for transmission of human T-lymphotropic virus type II infection by a human bite.

Authors:  W V Bolton; A R Davis; Y C Ge; D E Dwyer; K G Kenrick; A L Cunningham; N K Saksena
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.